Lokoregionale Tiefenhyperthermie verbessert das krankheitsspezifische Gesamtüberleben in Kombination mit einer neoadjuvanten Chemotherapie bei Hochrisiko-Weichteilsarkomen-Reference-Cited by-同舟云学术

Lokoregionale Tiefenhyperthermie verbessert das krankheitsspezifische Gesamtüberleben in Kombination mit einer neoadjuvanten Chemotherapie bei Hochrisiko-Weichteilsarkomen

Published:2018-06-07 Issue:8 Volume:194 Page:787-789
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:de
Short-container-title:Strahlenther Onkol

Author:

Eckert Franziska,Zips Daniel

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s00066-018-1322-2/fulltext.html

Reference8 articles.

1. Blay JY, Brahmi M, Ray-Coquard I (2017) European Journal of Cancer’s Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas. Eur J Cancer 70:83–86

2. Le Cesne A et al (2014) Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials. Ann Oncol 25(12):2425–2432

3. Issels RD et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11(6):561–570

4. Angele MK et al (2014) Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. Ann Surg 260(5):749–754 (discussion 754–6)

5. Issels RD et al (2018) Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial. Jama Oncol. https://doi.org/10.1001/jamaoncol.2017.4996